首页> 美国卫生研究院文献>Cancers >Advances in Nanocarriers for Effective Delivery of Docetaxel in the Treatment of Lung Cancer: An Overview
【2h】

Advances in Nanocarriers for Effective Delivery of Docetaxel in the Treatment of Lung Cancer: An Overview

机译:纳米载波的进展在治疗肺癌治疗中的多西紫杉醇:概述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

As lung cancer has the highest incidence rate compared to any other type of cancer, there have been extensive research studies aiming at finding a better treatment for curing this disease. One of the many approaches is by improving the delivery of anticancer drugs towards cancer cells using advanced technologies. In this review, we focused on docetaxel as one of the most commonly used drugs for lung cancer treatment and discussed the properties of the drug and the application of nanotechnology in delivering this drug to improve its efficacy and specificity while reducing its side effects.
机译:由于与任何其他类型的癌症相比,由于肺癌的发病率最高,因此有广泛的研究研究旨在找到治疗这种疾病的更好的治疗方法。许多方法之一是使用先进技术改善抗癌药物对癌细胞的递送。在这篇综述中,我们专注于多西紫杉醇作为肺癌治疗中最常用的药物之一,并讨论了药物的性质和纳米技术在递送该药物中的应用,以改善其疗效和特异性,同时降低其副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号